Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
General Mills $500 million notes offering
The investment-grade notes are due 2025
Natera $400 million follow-on offering
The shares are listed on Nasdaq
Texas Instruments $800 million notes offering
We advised Texas Instruments on its investment-grade debt offering
XPO Logistics cash tender offer
The tender offer involves 6.25% senior notes due 2025
Alight $178 million debut secondary offering
The stock is listed on the NYSE
Banco Santander renovation of $25 billion U.S. commercial paper program
We advised Banco Santander on its program renovation
Zoetis $1.35 billion senior notes offering
The investment-grade notes are due 2025 and 2032
Kinsale Capital Group follow-on offering
The stock is listed on the NYSE
Atour Lifestyle Holdings $52 million IPO
We advised Atour on its IPO and Nasdaq listing
Snail $15 million IPO
We advised Snail on its IPO and Nasdaq listing